Fig. 4: Biodistribution of DNAzyme-nanosponge in tumor-bearing mice.
From: Deoxyribozyme-nanosponges for improved photothermal therapy by overcoming thermoresistance
a In vivo photothermal images of DNAzyme, ICG, con-nanosponge-ICG-treated, and nanosponge-ICG-treated mice exposed to 808 nm laser with a power density of 2 W/cm2.b–d Biodistribution of ICG and nanosponge-ICG. b PA imaging of tumors from saline-treated, 0.1 mg/mL ICG-treated, and 5 μM nanosponge-treated mice 12 and 24 h after intravenous injection. c Fluorescence imaging of mice acquired 24 h after intravenous injection. d Fluorescence imaging of main organs treated with ICG and nanosponge-ICG 24 h after intravenous injection
